The clinical manifestation of DOLV was atypical. TTE has a relatively high diagnostic accuracy for DOLV in pediatric, which is very valuable for its early detection. ABSTRACT Double outlet left ventricle (DOLV) is a rare congenital cardiac anomaly in which both great arteries originate entirely or predominantly from the morphologic left ventricle.
Xu Zhu+6 more
wiley +1 more source
Polysplenia Syndrome and the Development of Heart Failure due to Associated Congenital Heart Defect. [PDF]
Van Ballaer V, Meersman P, Hustings N.
europepmc +1 more source
Endangered patients with congenital heart defect during transition-Germany-wide evaluation of medical data from National Register for Congenital Heart Defects (NRCHD). [PDF]
Remmele J+5 more
europepmc +1 more source
Chronic hypoxia: A model for cyanotic congenital heart defects [PDF]
Antonio F. Corno+4 more
openalex +1 more source
Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients
NIPBL variants (78.9%) dominate 19 Chinese pediatric Cornelia de Lange syndrome (CdLS). Universal craniofacial anomalies (94.7%) and developmental delay (84.2%) were observed. NIPBL null variants are associated with severe growth impairment and microcephaly, yet overall clinical severity remains heterogeneous, underscoring genotype‐phenotype complexity
Xiaoqiao Li+10 more
wiley +1 more source
Mediation role of health behaviours in the relation between mental resilience and cardiovascular risk in young adults with a diagnosed congenital heart defect. [PDF]
Mroczkowska R+3 more
europepmc +1 more source
Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase [PDF]
Qingping Feng+6 more
openalex +1 more source
ALK2 mutation in a patient with Down's syndrome and a congenital heart defect
I. Joziasse+12 more
semanticscholar +1 more source
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai+5 more
wiley +1 more source